[
    {
        "molecule_name": "anti-CD49a antibody",
        "protein_target_name": "CD49a",
        "binding_metric": "Kiapp",
        "value": "5 pM or less",
        "unit": "pM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−1",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−2",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−3",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−4",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−5",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−6",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−7",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−8",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−9",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−10",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−11",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    },
    {
        "molecule_name": "anti-CD49a",
        "protein_target_name": "CD49a",
        "binding_metric": "K_D",
        "value": "<10^−12",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The anti-CD49a antibody described herein has a Kiapp value of 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 40, 30, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5 pM or less for the target antigen or antigen epitope, such as an epitope of CD49a.\n* In some embodiments, the anti-CD49a binds to CD49a with a dissociation constant K<sub>D </sub>that is numerically lower (indicating tighter binding than) 10<sup>−1</sup>, 10<sup>−2</sup>, 10<sup>−3</sup>, 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, or 10<sup>−12</sup>, including ranges between any two of the listed values.\n* The apparent inhibition constant (Ki<sup>app </sup>or K<sub>i,app</sub>), which provides a measure of inhibitor potency, is related to the concentration of inhibitor required to reduce target (e.g., CD49a) activity and is not dependent on target concentrations, with a Kiapp value that can be determined using methods known in the art.\n* The anti-CD49a antibody as described herein binds to and inhibits the activity of CD49a by at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or greater, including any increment therein)."
    }
]